TLR9 and hepatocellular carcinoma: In brief, our findings indicate the pivotal role of HCQ in re-sensitizing sorafenib-resistant HCC cells to sorafenib by impeding autophagy and oxidative DNA damage stress via the TLR9/SOD1/hsa-miR-30a-5p/Beclin-1 axis.